Shanliang Zhong

机构：University Hospitals of Cleveland, Jiangsu Cancer Hospital, Nanjing Medical University · ORCID：0000-0001-8200-0511

发表论文 136 篇 · 总被引 6062 次 · h-index 47

代表论文

• Integrating single-cell RNA-seq and spatial transcriptomics reveals MDK-NCL dependent immunosuppressive environment in endometrial carcinoma (2023 · Frontiers in Immunology · 被引 84)
• Single-cell RNA-seq reveals MIF−(CD74 + CXCR4) dependent inhibition of macrophages in metastatic papillary thyroid carcinoma (2023 · Oral Oncology · 被引 24)
• Circular RNA HSDL2 promotes breast cancer progression via miR-7978 ZNF704 axis and regulating hippo signaling pathway (2024 · Breast Cancer Research · 被引 14)
• circNFIB decreases synthesis of arachidonic acid and inhibits breast tumor growth and metastasis (2023 · European Journal of Pharmacology · 被引 12)
• Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma (2023 · Frontiers in Oncology · 被引 7)
• Eleven inflammation-related genes risk signature model predicts prognosis of patients with breast cancer (2024 · Translational Cancer Research · 被引 6)